| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | A Giachetti | |
| C A Maggi | |||
| R Patacchini | |||
| P Rovero | |||
| P2860 | cites work | Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides | Q22242269 |
| Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones | Q24311743 | ||
| An unidentified depressor substance in certain tissue extracts | Q24540414 | ||
| Molecular characterisation, expression and localisation of human neurokinin‐3 receptor | Q28209225 | ||
| Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends | Q28274008 | ||
| Molecular cloning, structural characterization and functional expression of the human substance P receptor | Q28279939 | ||
| NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype | Q28283883 | ||
| Isolation and characterisation of the human lung NK-1 receptor cDNA | Q28305731 | ||
| Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems | Q28330800 | ||
| Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins | Q28337015 | ||
| Stable expression of high affinity NK1 (substance P) and NK2 (neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells | Q28343055 | ||
| Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing | Q31160220 | ||
| Further evidence for the existence of NK2 tachykinin receptor subtypes | Q33241565 | ||
| Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors | Q33241794 | ||
| Alterations in cat knee joint blood flow induced by electrical stimulation of articular afferents and efferents | Q33262404 | ||
| The non‐peptide NK1 receptor antagonist, (±)‐CP‐96,345, produces antinociceptive and anti‐oedema effects in the rat | Q42238959 | ||
| Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins | Q42278083 | ||
| Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis | Q42467148 | ||
| Tachykinin receptors in the circular muscle of the guinea-pig ileum | Q42562051 | ||
| Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345 | Q42710885 | ||
| Stimulation of connective tissue cell growth by substance P and substance K. | Q42815612 | ||
| Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea | Q42848928 | ||
| Regulation of epithelial transport in the jejunal mucosa of the guinea pig by neurokinins | Q43463625 | ||
| Substance P-like immunoreactivity in adrenal chromaffin cells and intra-adrenal nerve fibers of rats | Q43486931 | ||
| Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig | Q43516687 | ||
| Effects of actinomycin D on airway constriction induced by tachykinins and capsaicin in guinea-pigs | Q43518101 | ||
| Tachykinin receptors and noncholinergic bronchoconstriction in the guinea-pig isolated bronchi | Q43534445 | ||
| Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. | Q43678529 | ||
| Tachykinins and calcitonin gene-related peptide as co-transmitters in local motor responses produced by sensory nerve activation in the guinea-pig isolated renal pelvis. | Q43780079 | ||
| Pupillary supersensitivity to substance P following prolonged treatment with tetrodotoxin or substance P antagonists | Q43841333 | ||
| Further studies on the motor response of the human isolated urinary bladder to tachykinins, capsaicin and electrical field stimulation | Q43862254 | ||
| Substance P-, calcitonin gene-related peptide-and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis | Q43925730 | ||
| Effect of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH | Q43948451 | ||
| Substance P release from knee joint afferent terminals: modulation by opioids | Q44030680 | ||
| Heterogeneity of tachykinin-like immunoreactive peptides in rat spinal cord and dorsal root ganglia | Q44091468 | ||
| Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. | Q44185914 | ||
| Regional distribution of neuropeptide γ and other tachykinin peptides derived from the substance P gene in the rat | Q44215164 | ||
| Evidence for substance P as a functional neurotransmitter in guinea pig small intestinal mucosa | Q44288635 | ||
| Motor response of the human isolated colon to capsaicin and its relationship to release of vasoactive intestinal polypeptide. | Q44497126 | ||
| Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs | Q44500639 | ||
| Dactinomycin is a competitive neurokinin-2 receptor antagonist | Q44509636 | ||
| The effects of capsaicin upon electrogenic ion transport in rat descending colon | Q44518259 | ||
| Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells | Q44625214 | ||
| In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist | Q44787444 | ||
| Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides | Q44951761 | ||
| Presence of various carbohydrate moieties including beta-galactose and N-acetylglucosamine residues on solubilized porcine brain neurokinin-1/substance P receptors | Q45202013 | ||
| Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence | Q45230937 | ||
| Role of central tachykinin peptides in cardiovascular regulation in rats | Q45238582 | ||
| Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction | Q46008800 | ||
| Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery | Q46128636 | ||
| Substance P antagonists showing some selectivity for different receptor types | Q46143344 | ||
| Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles | Q46175012 | ||
| A synthetic peptide that is a bombesin receptor antagonist | Q46175289 | ||
| Activity of peptide and non-peptide antagonists at peripheral NK1 receptors | Q46185121 | ||
| Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation | Q46256671 | ||
| Substance P enteric neurons mediate non-cholinergic transmission to the circular muscle of the guinea-pig intestine | Q46357246 | ||
| A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation | Q46380348 | ||
| In vivo and in vitro actions of mammalian tachykinins | Q46532142 | ||
| Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder | Q46558511 | ||
| Use of substance P fragments to differentiate substance P receptors of different tissues | Q46570554 | ||
| Neurokinin receptors antagonists: old and new. | Q46588584 | ||
| Intestinal peristalsis associated with release of immunoreactive substance P | Q46598921 | ||
| Multiple tachykinin binding sites in peripheral tissues and in brain | Q46609145 | ||
| Effects of selective tachykinin receptor antagonists on capsaicin- and tachykinin-induced bronchospasm in anaesthetized guinea-pigs | Q46628082 | ||
| Structure-activity studies of neurokinin A. | Q46686837 | ||
| Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. | Q50886925 | ||
| Capsaicin induced release of multiple tachykinins (substance P, neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter. | Q50907967 | ||
| Plasma extravasation in the cat knee-joint induced by antidromic articular nerve stimulation. | Q50916209 | ||
| Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins | Q50919872 | ||
| Substance P-Evoked release of GABA from isolated spinal cord of the newborn rat | Q51721713 | ||
| Mediators of substance P-induced inflammation in the rat knee joint | Q51725469 | ||
| Evidence for an involvement of substance P, but not cholecystokinin-like peptides, in hexamethonium-resistant intestinal peristalsis. | Q51762780 | ||
| Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A. | Q51787780 | ||
| Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetized cat. | Q51803208 | ||
| Comparison of the effects of substance P and substance K on blood pressure, salivation and urinary bladder motility in urethane-anaesthetized rats. | Q51824548 | ||
| Evidence for the involvement of endogenous substance P in the motor effects of capsaicin on the rat urinary bladder. | Q51830587 | ||
| Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. | Q51847574 | ||
| Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonist | Q51851683 | ||
| On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat. | Q52239152 | ||
| Ultrastructural localisation of serotonin and substance P in vascular endothelial cells of rat femoral and mesenteric arteries. | Q52254068 | ||
| Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist | Q53845785 | ||
| Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay) | Q53859757 | ||
| Tachykinin receptors in the guinea-pig isolated bronchi. | Q53859914 | ||
| Comparison of the presence and actions of substance P and neurokinin A in guinea-pig taenia coli. | Q53860653 | ||
| Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain | Q53863667 | ||
| Activity and Distribution of Binding Sites in Brain of a Nonpeptide Substance P (NK 1 ) Receptor Antagonist | Q53863671 | ||
| Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man | Q53917173 | ||
| Influence of perivascular peptides on endoneurial blood flow and microvascular resistance in the sciatic nerve of the rat | Q54284273 | ||
| In vitro effects of substance P on neonatal rat sympathetic preganglionic neurones. | Q54385053 | ||
| The possible existence of multiple receptors for substance P | Q55062375 | ||
| Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract | Q58449288 | ||
| Fertilization of Denuded Rabbit Eggs in vitro by Sperm recovered from the Uterus or Vagina | Q59067575 | ||
| Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease | Q33571955 | ||
| Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation | Q33830293 | ||
| Molecular characterization of a functional cDNA encoding the rat substance P receptor | Q33891305 | ||
| Competitive antagonists discriminate between NK2 tachykinin receptor subtypes | Q33933966 | ||
| Substance P receptor binding sites are expressed by glia in vivo after neuronal injury | Q34288573 | ||
| Asthma as an axon reflex | Q34382020 | ||
| Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A | Q34594580 | ||
| Role of NK1 tachykinin receptors in thermonociception: Effect of (±)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice | Q34599054 | ||
| Depolarizing influences regulate preprotachykinin mRNA in sympathetic neurons | Q34641526 | ||
| Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone | Q35118849 | ||
| Therapeutic potential of capsaicin-like molecules: studies in animals and humans | Q35528847 | ||
| Intragastric capsaicin enhances rat gastric acid elimination and mucosal blood flow by afferent nerve stimulation | Q35756165 | ||
| Effects of capsaicin pretreatment on neuropeptides and salivary secretion of rat parotid glands | Q35756650 | ||
| NK-1 receptor mediation of neurogenic plasma extravasation in rat skin | Q35756691 | ||
| Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission | Q35871938 | ||
| The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation | Q35872152 | ||
| Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist | Q35872417 | ||
| A tachykinin antagonist inhibits gastric emptying and gastrointestinal transit in the rat. | Q35887462 | ||
| Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury | Q36004414 | ||
| cDNA cloning of bovine substance-K receptor through oocyte expression system. | Q36288721 | ||
| NK-2 receptor agonists and antagonists | Q36440037 | ||
| Pain and neurotransmitters | Q36609561 | ||
| Concepts in Characterization of Tachykinin Receptors | Q36697019 | ||
| Substance P interactions with the nicotinic response. | Q36697074 | ||
| The Tachykinin Neuroimmune Connection in Inflammatory Pain | Q36697090 | ||
| Substance P and neurodegenerative disorders. A speculative review | Q36716659 | ||
| Structure and gene organization of bovine neuromedin K precursor | Q37400075 | ||
| Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells | Q37412709 | ||
| Precursor forms of substance P (SP) in nervous tissue: detection with antisera to SP, SP-Gly, and SP-Gly-Lys | Q37541699 | ||
| Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin | Q37554258 | ||
| Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats | Q37617969 | ||
| Pharmacological properties of a potent and selective nonpeptide substance P antagonist | Q37621800 | ||
| Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions | Q37748431 | ||
| Substance P and Arg-Pro-Lys-Pro-NH-C12-H25-induced mediator release from different mast cell subtypes of rat and guinea-pig | Q46694592 | ||
| Autoradiographic mapping of substance P receptors in lung | Q46711911 | ||
| Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes | Q46713541 | ||
| Release of substance P- and substance K-like immunoreactivities from the isolated perfused guinea-pig lung | Q46766188 | ||
| Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra | Q46796361 | ||
| Interaction of amyloid beta protein (25-35) with tachykinin receptors | Q46829086 | ||
| Imidazo[4,5-b]quinoxaline cyanines as neurokinin antagonists | Q46863056 | ||
| [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors | Q46873316 | ||
| Potent and highly selective neurokinin antagonists | Q46886862 | ||
| Conversion of neuropeptide K to neurokinin A and vesicular colocalization of neurokinin A and substance P in neurons of the guinea pig small intestine | Q46925262 | ||
| Species differences in affinities of non-peptide antagonists for substance p receptors | Q46925772 | ||
| Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes | Q47575135 | ||
| Substance P levels differ in sympathetic target organ terminals and ganglion perikarya | Q47734893 | ||
| Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain | Q48108880 | ||
| Neuropeptides and their peptidases: Functional considerations | Q48124573 | ||
| The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. | Q48167486 | ||
| Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system | Q48265472 | ||
| Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system | Q48283640 | ||
| Substance P antagonists in substantia nigra are anticonvulsant | Q48299053 | ||
| Behavioural effects of tachykinins and related peptides | Q48309587 | ||
| In vivo release of substance P in the nucleus tractus solitarii increases during hypoxia | Q48310888 | ||
| Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing | Q48384593 | ||
| Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area | Q48386085 | ||
| Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor | Q48395090 | ||
| Regional distribution of substance P, neurokinin alpha and neurokinin beta in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection | Q48427028 | ||
| Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro | Q48459178 | ||
| Substance K excites dopaminergic and non-dopaminergic neurons in rat substantia nigra | Q48480241 | ||
| The substance P receptor subtype modulating catecholamine release from adrenal chromaffin cells | Q48496330 | ||
| Distribution of neurons expressing neurokinin B in the rat brain: immunohistochemistry and in situ hybridization | Q48506705 | ||
| Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. | Q48507580 | ||
| Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins | Q48519093 | ||
| Characterization of substance P-like immunoreactivity and tachykinin-encoding mRNAs in rat medullary thyroid carcinoma cell lines | Q48521722 | ||
| Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn | Q48534576 | ||
| Substance K and substance P differentially modulate mesolimbic and mesocortical systems | Q48587478 | ||
| Regional distribution of substance P, neurokinin α and neurokinin β in rat central nervous system | Q48599826 | ||
| Novel Pharmacology of Substance K-Binding Sites: a Third Type of Tachykinin Receptor | Q48600937 | ||
| Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain | Q48608355 | ||
| Binding sites for [3H][Sar9, Met(O2)11]substance P in rat bain and guinea pig ileum | Q48653617 | ||
| Substance P in the rat parotid gland: evidence for a dual origin from the otic and trigeminal ganglia | Q48656091 | ||
| Role of D-tryptophan for affinity of MEN 10207 tachykinin antagonist at NK2 receptors | Q48668004 | ||
| Species differences between [3h] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists | Q48670130 | ||
| Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism | Q48768042 | ||
| Role of NK-2 receptors in the antidipsogenic activity of neurokinins in the mouse | Q48847320 | ||
| Localization of neuropeptide receptor mRNA in rat brain: Initial observations using probes for neurotensin and substance P receptors | Q48857796 | ||
| Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor | Q48920304 | ||
| [125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain | Q48943621 | ||
| Inhibition of salt appetite in the rat following injection of tachykinins into the medial amygdala | Q49022500 | ||
| NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: Demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207 | Q50793165 | ||
| Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors | Q50798603 | ||
| Cigarette smoke-induced airway oedema is blocked by the NK1 antagonist, CP-96,345 | Q50800418 | ||
| Tachykinin receptor types: Classification and membrane signalling mechanisms | Q37760972 | ||
| G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. | Q37827766 | ||
| Tachykinin receptors in the airways and lung: what should be block? | Q37903173 | ||
| Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon | Q38156461 | ||
| "Kassinin" in mammals: the newest tachykinins | Q38161330 | ||
| Search for a physiological role of substance P in gastrointestinal motility | Q38163187 | ||
| Pharmacological receptors for substance P and neurokinins | Q38170054 | ||
| Arthritis and the nervous system | Q38201398 | ||
| New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization | Q39332972 | ||
| The sensory-efferent function of capsaicin-sensitive sensory neurons | Q39631475 | ||
| Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides | Q39645839 | ||
| Substance P and multiple sclerosis | Q41092137 | ||
| The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. | Q41137377 | ||
| Tachykinin-mediated modulation of the primary antibody response in rats: evidence for mediation by an NK-2 receptor | Q41138481 | ||
| Tachykinin-like immunoreactivity in the mammalian urinary bladder: correlation with the functions of the capsaicin-sensitive sensory nerves | Q41253919 | ||
| Spinal action of neurokinins producing cardiovascular responses in the conscious freely moving rat: evidence for a NK-1 receptor mechanism | Q41256172 | ||
| Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour | Q41372294 | ||
| Demonstration of a neurokinin A receptor subtype in transfected fibroblasts | Q41640120 | ||
| Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line | Q41642073 | ||
| Multiple NK2 receptor subtypes are suggested by physiological and biochemical studies with neurokinin A (NKA) analogues and antagonists | Q41708952 | ||
| [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a neuropeptide antagonist, blocks binding, Ca2(+)-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells. | Q41720904 | ||
| Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells | Q41724135 | ||
| Biological evaluation of substance P antagonists | Q41741345 | ||
| A study of [d-Pro2, d-Phe7, d-Trp9]-substance P and [d-Trp7,9]-substance P as tachykinin partial agonists in the rat colon | Q41742767 | ||
| Different substance P receptors are found on mucosal epithelial cells and submucous neurons of the guinea-pig small intestine. | Q41768394 | ||
| Selective localization of vasoactive intestinal peptide and substance P in human eosinophils | Q41784502 | ||
| Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors | Q41811618 | ||
| Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens | Q41823272 | ||
| Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum | Q41843309 | ||
| Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. | Q41856571 | ||
| NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins | Q41861649 | ||
| Differences in neurokinin receptor pharmacology between rat and guinea-pig superior cervical ganglia | Q41864232 | ||
| Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists | Q41885307 | ||
| Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation | Q41943134 | ||
| Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery | Q41983251 | ||
| Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea | Q41984021 | ||
| The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP. | Q41984028 | ||
| An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes | Q41985800 | ||
| Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat | Q41990391 | ||
| Bronchodilatation by tachykinins and capsaicin in the mouse main bronchus | Q42020312 | ||
| Intramural neurons of the guinea-pig urinary bladder: histochemical localization of putative neurotransmitters in cultures and newborn animals | Q42030998 | ||
| Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation | Q42051498 | ||
| Stimulatory effect of substance P on sympathetic ganglia and spinal cord in culture | Q42098468 | ||
| Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptors | Q42106654 | ||
| Substance P is released from the endothelium of normal and capsaicin-treated rat hind-limb vasculature, in vivo, by increased flow | Q42130399 | ||
| Tachykinin antagonists have potent local anaesthetic actions | Q42148905 | ||
| Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography | Q42197644 | ||
| Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors | Q42213248 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tachykinin receptor | Q426034 |
| P304 | page(s) | 23-93 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | Autonomic and Autacoid Pharmacology | Q15754246 |
| P1476 | title | Tachykinin receptors and tachykinin receptor antagonists | |
| P478 | volume | 13 |
| Q28368884 | 'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro |
| Q33977964 | 3-benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis |
| Q43692536 | A flexible approach to the design of new potent substance P receptor ligands |
| Q47728062 | A method to measure dual NK1/NK2-antagonist activity in dogs |
| Q77744497 | A novel super-potent neurokinin A receptor antagonist containing dehydroalanine |
| Q44297334 | A tachykinin-like factor increases glutamate toxicity in rat cerebellar granule cells. |
| Q46701237 | AMPA receptors are modulated by tachykinins in rat cerebellum neurons |
| Q71237568 | Absorption of Cam-2445, and NK1 neurokinin receptor antagonist: in vivo, in situ, and in vitro evaluations |
| Q35040768 | Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer |
| Q41143394 | Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation |
| Q24322842 | Altered nociception, analgesia and aggression in mice lacking the receptor for substance P |
| Q77153157 | An investigation of tachykinin NK2 receptor subtypes in the rat |
| Q43967464 | Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway. |
| Q36621139 | Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft |
| Q37039597 | Antiemetics: an update and the MASCC guidelines applied in clinical practice |
| Q44239828 | Application of LC-NMR for the study of the volatile metabolite of MK-0869, a substance P receptor antagonist |
| Q24676229 | Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules |
| Q48085106 | Autonomic & Autacoid Pharmacology: past, present and future |
| Q46610523 | Autoradiographic mapping of pulmonary NK1 and NK2 tachykinin receptors and changes after repeated antigen challenge in guinea pigs |
| Q44512655 | Biologic activity of the tachykinins on lamb and sheep gallbladder |
| Q58234708 | Building a model of interaction at the NK-2 receptors: Polycondensed heterocycles containing the pyrimidoindole skeleton |
| Q42097975 | Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization |
| Q24679394 | Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists |
| Q51420898 | Cellular and synaptic effect of substance P on neonatal phrenic motoneurons. |
| Q73153568 | Cellular localization and distribution of neurokinin-1 receptors in the rat stomach |
| Q46686742 | Cellular sites of expression of the neurokinin‐1 receptor in the rat gastrointestinal tract |
| Q73978655 | Central and peripheral antiulcer and antisecretory effects of Ala5NKA(4-10), a tachykinin NK2 receptor agonist, in rats |
| Q35026070 | Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat. |
| Q46150974 | Characterisation of substance P-induced endocytosis of NK1 receptors on enteric neurons |
| Q42063978 | Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems |
| Q48493896 | Characterization of actions of Leucophaea tachykinin-related peptides (LemTRPs) and proctolin on cockroach hindgut contractions |
| Q41821983 | Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. |
| Q43179592 | Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct |
| Q52075495 | Characterization of substance P-membrane interaction by transferred nuclear Overhauser effect. |
| Q73031669 | Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968 |
| Q35027108 | Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat. |
| Q36826373 | Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat |
| Q35029104 | Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon |
| Q73862905 | Co-distribution of NK2 tachykinin receptors and substance P in nerve endings of guinea-pig ileum |
| Q46670511 | Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues |
| Q41872098 | Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig |
| Q46967061 | Comparative effects of nonpeptide tachykinin receptor antagonists on experimental gut inflammation in rats and guinea-pigs |
| Q38336515 | Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. |
| Q42117930 | Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. |
| Q43680602 | Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor. |
| Q77748933 | Conformational probes for elucidating the nature of substance P binding to the NK1 receptor: initial efforts to map the Phe7-Phe8 region |
| Q41508037 | Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P. |
| Q44604761 | Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs |
| Q35623447 | Correlation between the appearance of neuropeptides in the rat trigeminal ganglion and reinnervation of the healing root socket after tooth extraction |
| Q36568728 | Current and emerging investigational medical therapies for the treatment of overactive bladder |
| Q35874664 | Cutaneous vasodilatation induced by nitric oxide‐evoked stimulation of afferent nerves in the rat |
| Q74623154 | Defects of tyrosine289phenylalanine mutation on binding and functional properties of the human tachykinin NK2 receptor stably expressed in chinese hamster ovary cells |
| Q42146190 | Demonstration of a 'septide-sensitive' inflammatory response in rat skin |
| Q43565356 | Depression of windup of spinal neurons in the neonatal rat spinal cord in vitro by an NK3 tachykinin receptor antagonist |
| Q43552127 | Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold |
| Q42735567 | Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist |
| Q74570838 | Design, synthesis and biological activity of carbohydrate-containing peptidomimetics as new ligands for the human tachykinin NK-2 receptor |
| Q74508047 | Development and application of sensitive HPLC assays for NK3 antagonists in rat plasma |
| Q48268125 | Diencephalic neurons producing melanin-concentrating hormone are influenced by local and multiple extra-hypothalamic tachykininergic projections through the neurokinin 3 receptor |
| Q72113837 | Different mechanism of tachykinin NK2 receptor blockade by SR 48968 and MEN 10,627 in the guinea-pig isolated gallbladder and colon |
| Q43172881 | Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea |
| Q43625228 | Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation |
| Q28583147 | Direct evidence for the interaction of neurokinin A with the tachykinin NK(1) receptor in tissue |
| Q74327497 | Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide |
| Q41836203 | Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm |
| Q71378260 | Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon |
| Q43540654 | Effect of a tachykinin NK(2) receptor antagonist, nepadutant, on cardiovascular and gastrointestinal function in rats and dogs |
| Q36922574 | Effect of chronic, extrinsic denervation on functional NANC innervation with vasoactive intestinal polypeptide and substance P in longitudinal muscle of rat jejunum |
| Q22254329 | Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder |
| Q73302803 | Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea |
| Q74515937 | Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon |
| Q71771547 | Effect of the non-peptide blocker (+/-) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts |
| Q41790903 | Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord |
| Q71549319 | Effect of the tachykinin receptor antagonists, SR 140333, FK 888, and SR 142801, on capsaicin-induced mouse ear oedema |
| Q54543921 | Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder. |
| Q34079164 | Effects of tachykinin receptor agonists and antagonists on the guinea-pig isolated oesophagus |
| Q34079159 | Effects of tachykinins on uterine smooth muscle |
| Q42370128 | Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B. |
| Q42447559 | Electrophysiological evidence that neurokinin A acts via NK-1 receptors in the cat dorsal horn |
| Q77209775 | Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction |
| Q49080608 | Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation |
| Q51520191 | Evaluation of PD 154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain. |
| Q41979276 | Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum |
| Q38561929 | Evidence that tachykinin NK2 receptors modulate resting tone in the rat isolated small intestine |
| Q43185063 | Evidence that tachykinins are the main NANC excitatory neurotransmitters in the guinea-pig common bile duct. |
| Q42144915 | Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor |
| Q34397958 | Evolution of vertebrate neuropeptides |
| Q35028104 | Excitatory motor and electrical effects produced by tachykinins in the human and guinea-pig isolated ureter and guinea-pig renal pelvis |
| Q34737724 | Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells |
| Q48388973 | Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. |
| Q77361337 | Expression of neurokinin-1 receptors on cultured dorsal root ganglion neurons from the adult rat |
| Q45750848 | Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system |
| Q41319496 | From acute to chronic pain: mechanisms and hypotheses. |
| Q48616401 | Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production |
| Q42704618 | Functional evidence for NO-synthase activation by substance P through a mechanism not involving classical tachykinin receptors in guinea-pig ileum in vitro. |
| Q24312052 | Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists |
| Q34793277 | Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. |
| Q41836224 | Identification of both NK1 and NK2 receptors in guinea‐pig airways |
| Q40285095 | Immunolocalization of full-length NK1 tachykinin receptors in human tumors |
| Q32144991 | Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P. |
| Q35027804 | Impaired IL-1beta-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice |
| Q41095765 | Improved discriminatory properties between human and murine tachykinin NK1 receptors of MEN 10930: a new potent and competitive antagonist |
| Q35027801 | In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips |
| Q42369007 | Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo |
| Q71726618 | Inhibition by actinomycin D of neurogenic mouse ear oedema |
| Q41840406 | Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins |
| Q73024991 | Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi |
| Q60733559 | Internalization of the neurokinin 1 receptor in rat myenteric neurons |
| Q35874499 | Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist |
| Q52207115 | Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. |
| Q37617971 | Involvement of substance P and the NK-1 receptor in pancreatic cancer |
| Q70992664 | Involvement of substance P as a mediator in capsaicin-induced mouse ear oedema |
| Q42494051 | Involvement of tachykinin NK2 receptors in the modulation of spontaneous motility in rat proximal colon |
| Q36718238 | Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery |
| Q46433088 | Localisation of NK1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract |
| Q36309083 | Localization of neurokinin B receptor in mouse gastrointestinal tract |
| Q80625357 | Long-term effects of extrinsic denervation on VIP and substance P innervation in circular muscle of rat jejunum |
| Q37380509 | Lung respiratory rhythm and pattern generation in the bullfrog: role of neurokinin-1 and mu-opioid receptors |
| Q28379348 | MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist |
| Q73188535 | Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats |
| Q40616888 | Membrane-induced structure of novel human tachykinin hemokinin-1 (hHK1). |
| Q54187439 | Metabolic stability of some tachykinin analogues to cell-surface peptidases: Roles for endopeptidase-24.11 and aminopeptidase N |
| Q71720526 | Modulation of gut substance P after whole-body irradiation. A new pathological feature |
| Q43231195 | Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists |
| Q43260751 | Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle |
| Q32065075 | Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor |
| Q73807935 | Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis |
| Q43254445 | NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals |
| Q71652591 | NK1 and NK2 receptors are similar in man and rabbit |
| Q73413996 | NK1 receptor expression in the interstitial cells of Cajal and neurons and tachykinins distribution in rat ileum during development |
| Q71980784 | NK1-tachykinin receptors and prolonged, stimulus-evoked alterations in the excitability of withdrawal reflexes in the decerebrated and spinalized rabbit |
| Q73426217 | NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats |
| Q80686325 | Neurogenic inflammation in lung disease: burnt out? |
| Q41319571 | Neurogenic mechanisms and neuropeptides in chronic pain |
| Q35042205 | Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig |
| Q77425680 | Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum |
| Q48451417 | Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway. |
| Q33905991 | Neurokinin receptor antagonists |
| Q41143437 | Neurokinin receptors subserving airways secretion |
| Q41143430 | Neurokinin receptors subserving bronchoconstriction |
| Q48628404 | Neurokinin-1 and neurokinin-3 receptors are expressed in vagal efferent neurons that innervate different parts of the gastro-intestinal tract |
| Q43814498 | Neuronal bursting induced by NK3 receptor activation in the neonatal rat spinal cord in vitro |
| Q77748966 | Neuronorm is a potent and water soluble neurokinin A receptor antagonist |
| Q47103471 | Neuropeptides and ATP signaling in the trigeminal ganglion |
| Q34655147 | Neuropeptides in hyperthermia |
| Q46584544 | Nitric oxide induces acetylcholine-mediated contractions in the guinea-pig small intestine |
| Q35874315 | Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission |
| Q40041782 | Novel anti-inflammatory treatments for asthma |
| Q41293781 | Novel pharmacological strategies for analgesia |
| Q44057884 | Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives |
| Q46799249 | Oxidative stress and substance P mediate psychological stress-induced autophagy and delay of hair growth in mice |
| Q46323752 | Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship. |
| Q51536511 | Peptidergic activation of locust dorsal unpaired median neurons: depolarization induced by locustatachykinins may be mediated by cyclic AMP. |
| Q51554681 | Peripheral effects of three novel non-peptide tachykinin NK1 receptor antagonists in the anaesthetized rat. |
| Q28204105 | Peripheral tachykinin receptors as targets for new drugs |
| Q36955876 | Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. |
| Q24673375 | Pharmacological profile of the novel mammalian tachykinin, hemokinin 1 |
| Q74446250 | Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist |
| Q34060762 | Principles of tachykininergic co-transmission in the peripheral and enteric nervous system |
| Q48634338 | Profile of neuronal excitation following selective activation of the neurokinin-1 receptor in rat deep dorsal horn in vitro |
| Q44652916 | RNA interference prevents lipopolysaccharide-induced preprotachykinin gene expression |
| Q41471400 | Rational design of high affinity tachykinin NK1 receptor antagonists |
| Q36430845 | Relationships between neurokinin receptor-expressing interstitial cells of Cajal and tachykininergic nerves in the gut. |
| Q42037304 | Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization |
| Q78113199 | Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists |
| Q40085168 | Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis |
| Q28368251 | Role of intrathecal tachykinins for micturition in unanaesthetized rats with and without bladder outlet obstruction |
| Q59852872 | Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant |
| Q35041990 | Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs |
| Q73221775 | Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs |
| Q33899646 | Role of tachykinins in asthma |
| Q42458136 | Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis |
| Q36105763 | Selective and combined neurokinin receptor antagonists |
| Q53319380 | Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness. |
| Q41664954 | Sensory neuropeptides: their role in inflammation and wound healing |
| Q73404424 | Sequential activation of the triple excitatory transmission to the circular muscle of guinea-pig colon |
| Q43004987 | Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea |
| Q78048899 | Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist |
| Q40940881 | Spinal cord tachykinins in the micturition reflex. |
| Q71657322 | Structural comparison of NK2 receptor agonists and antagonists |
| Q32148641 | Structure determination and by-product profile of the NK(2) receptor antagonist nepadutant, a bicyclic glycopeptide |
| Q36179745 | Structure-based design in drug discovery--the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands |
| Q90599304 | Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes |
| Q42695078 | Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R. |
| Q40980907 | Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors |
| Q41911986 | Substance P and Neurokinin 1 receptor - expression is affected in the ileum of mice with mutation in the W locus |
| Q43713612 | Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. |
| Q71911949 | Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts |
| Q34075030 | Substance P antagonists: novel agents in the treatment of depression |
| Q36592563 | Substance P enhances the activation of AMPK and cellular lipid accumulation in 3T3‑L1 cells in response to high levels of glucose |
| Q46626690 | Substance P immunoreactive nerves and interstitial cells of Cajal in the rat and guinea-pig ileum. A histochemical and quantitative study |
| Q74529110 | Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: a c-Fos study in rat |
| Q30837190 | Substance P-evoked Cl(-) secretion in guinea pig distal colonic epithelia: interaction with PGE(2). |
| Q46161774 | Synergistic role of muscarinic acetylcholine and tachykinin NK-2 receptors in intestinal peristalsis |
| Q71788406 | Synthesis and biological evaluation of novel NK‐1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template |
| Q42165713 | Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides |
| Q28577874 | Tachykinin NK(2) receptor mediates contraction and ion transport in rat colon by different mechanisms |
| Q51660620 | Tachykinin NK-1 and NK-2 receptors in the circular muscle of the guinea-pig proximal colon |
| Q42700984 | Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum |
| Q51631464 | Tachykinin NK1 and NK2 receptors mediate atropine-resistant ileal circular muscle contractions evoked by capsaicin |
| Q24673126 | Tachykinin NK1 and NK2 receptors mediate inhibitory vs excitatory motor responses in human isolated corpus cavernosum and spongiosum |
| Q46883653 | Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach |
| Q73557239 | Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum |
| Q41835345 | Tachykinin NK1 but not NK2 receptors mediate non-cholinergic excitatory junction potentials in the circular muscle of guinea-pig colon |
| Q37965737 | Tachykinin NK2 receptor antagonists. A patent review (2006 - 2010). |
| Q34400995 | Tachykinin NK2 receptors further characterized in the lung with nonpeptide receptor antagonists |
| Q52868098 | Tachykinin actions on deep dorsal horn neurons in vitro: an electrophysiological and morphological study in the immature rat. |
| Q48702539 | Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study |
| Q37638682 | Tachykinin receptor antagonists in clinical trials |
| Q34147318 | Tachykinin receptor assays. |
| Q46843069 | Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus |
| Q40465220 | Tachykinin receptors in gastrointestinal motility |
| Q43169440 | Tachykinin receptors in the guinea-pig isolated oesophagus: a complex system |
| Q42875520 | Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors |
| Q48887663 | Tachykinins and central respiratory activity: an in vitro study on the newborn rat. |
| Q34803993 | Tachykinins and tachykinin receptors in bone |
| Q41491263 | Tachykinins in the gut. Part I. Expression, release and motor function |
| Q44537826 | Tachykinins mediate non-adrenergic, non-cholinergic excitatory neurotransmission to the hamster ileum via NK1 and NK2 receptors |
| Q41209277 | Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases |
| Q41093430 | Targeting neurokinin-3 receptor: a novel anti-angiogenesis strategy for cancer treatment |
| Q57110771 | Temporal increase in the reactivity of pulmonary vasculature to substance P in chronically hypoxic rats |
| Q35967286 | The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction |
| Q34369831 | The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety |
| Q41633157 | The dual nature of the tachykinin NK1 receptor. |
| Q39377879 | The effects of NK-1 and NK-2 receptor antagonists on the capsaicin evoked synaptic response in the rat spinal cord in vitro |
| Q41578664 | The effects of tachykinins on inflammatory and immune cells |
| Q34975942 | The guinea-pig oesophagus is a versatile in vitro preparation for pharmacological studies |
| Q48829249 | The neostriatal mosaic: basis for the changing distribution of neurokinin-1 receptor immunoreactivity during development |
| Q73980279 | The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat |
| Q74268477 | The neurokinin-2 receptor is not involved in the sensitization of primary afferents of the rat knee joint |
| Q74313940 | The nonpeptide NK-1 receptor antagonists LY303870 and LY306740 block the responses of spinal dorsal horn neurons to substance P and to peripheral noxious stimuli |
| Q42706973 | The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist |
| Q48503485 | The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P. |
| Q48391175 | The role of substance P in cerebral ischemia |
| Q44361751 | The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitization |
| Q43749930 | The roles of the N-terminal portions of various tachykinins in promoting salivation |
| Q28141864 | The tachykinin NK1 receptor in the brain: pharmacology and putative functions |
| Q71345757 | The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture |
| Q29306227 | The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation |
| Q41757345 | The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles |
| Q74400952 | Three-dimensional quantitative structure-activity relationship for several bioactive peptides searched by a convex hull-comparative molecular field analysis approach |
| Q60678323 | Topical acetyl salicylate and dipyrone attenuate neurogenic protein extravasation in rat skin in vivo |
| Q54074159 | Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. |
| Q32061436 | Transglutaminase-synthesized gamma-(glutamyl5) spermidine derivative of substance P is a selective tool for neurokinin-2 receptors characterization. |
| Q73070134 | Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors |
| Q42701410 | Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter |
| Q52507637 | Vascular bed-dependent roles of the peptide CGRP and nitric oxide in acid-evoked hyperaemia of the rat stomach. |
| Q81092905 | [Neurobiological mechanisms of muscle pain referral.]. |
Search more.